| Structure |
Chemical Name |
CAS |
MF |
 |
Cefazolin USP Impurity E |
|
|
|
|
Mirabegron Impurity 19 |
|
|
|
|
Exemestane Impurity 5 |
|
|
![9-[(Z)-1-プロペニル]-9H-プリン-6-アミン](/CAS/20180703/GIF/1464851-21-5.gif) |
9-[(Z)-1-プロペニル]-9H-プリン-6-アミン |
1464851-21-5 |
C8H9N5 |
|
|
Moxifloxacin impurity (20) |
|
|
 |
Medetomidine Impurity 28 |
2240179-64-8 |
C23H28N2 |
 |
Peramivir Impurity 4 |
229615-12-7 |
C15H28N4O4 |
 |
(R)-2-(2-(tert-butoxy)-2-oxoethyl)pentanoic acid |
112106-16-8 |
C11H20O4 |
|
|
Bazedoxifene impurity |
|
|
|
|
Peramivir Impurity 9 |
|
|
 |
Tamsulosin impurity |
1429436-97-4 |
C20H28N2O5S |
|
|
PidotimodImpurity T |
|
|
 |
(Z)-methyl 3-(hydroxy(phenyl)methylene)-2-oxoindoline-6-carboxylate |
2093243-16-2 |
C17H13NO4 |
 |
Clarithromycin (9Z)-Oxime |
127253-05-8 |
C38H70N2O13 |
|
|
Lenvatinib Impurity 10 |
|
|
 |
N-Desmethyl Clarithromycin (9E)-Oxime |
127182-43-8 |
C37H68N2O13 |
|
|
Labetalol EP impurity G |
|
|
 |
2-(2-NITROPHENYL)ETHANAMINE |
33100-15-1 |
C8H10N2O2 |
|
|
Empagliflozin Impurity 79 |
|
|
 |
Empagliflozin Impurity 89 |
2452301-32-3 |
C23H25ClO7 |
 |
Levocarnitine Impurity F |
6490-19-3 |
C7H17ClN2O2 |
 |
4,4-dimethyl-2-(2-phenylpropan-2-yl)oxazo‐ line |
874895-87-1 |
C14H19NO |
|
|
Formoterol Impurity 4 |
|
|
 |
Roxadustat-001 |
319-57-3 |
C8H5BF4N2O2 |
|
|
Ornidazole Impurity 24 |
|
|
|
|
Olanzapine impurity ANB |
|
|
|
|
Pitavastatin Impurity 75 |
|
|
|
|
Febuxostat Impurity 100 |
|
|
 |
CLOZAPINE-D3 |
1215691-72-7 |
C18H19ClN4 |
|
|
Bendamustine Impurity 25 |
|
|
|
|
Canagliflozin Impurity 25 |
|
|
 |
Edoxaban Impurity 41 |
1353893-25-0 |
C14H27N3O3 |
|
|
Istradefylline Impurity 5 |
|
|
|
|
Milrinone Impurity 10 |
|
|
 |
Olanzapine Impurity 3 |
|
C17H20N4S |
|
|
Ticagrelor Related Compound 54 |
|
|
|
|
Blonanserin Impurity N |
|
|
|
|
Brexpiprazole Impurity N |
|
|
|
|
Cefaclor Impurity 1 |
|
|
|
|
Cefminox Sodium impurity 4 |
|
|
|
|
Cefradine Impurity B |
|
|
|
|
Dapoxetine Impurity F |
|
|
|
|
Olaparib Impurity E |
|
|
 |
Cefathiamidine Impurity 6 |
28240-16-6 |
C12H13ClN2O6S |
![rac-2,2'-(((3aR,3a'R,4R,4'R,6S,6aS,6'S,6a'S)-((5-nitro-2-(propylthio)pyrimidine-4,6-diyl)bis(azanediyl))bis(2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxole-6,4-diyl))bis(oxy))bis(ethan-1-ol)](/CAS/20211123/GIF/1882095-50-2.gif) |
rac-2,2'-(((3aR,3a'R,4R,4'R,6S,6aS,6'S,6a'S)-((5-nitro-2-(propylthio)pyrimidine-4,6-diyl)bis(azanediyl))bis(2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxole-6,4-diyl))bis(oxy))bis(ethan-1-ol) |
1882095-50-2 |
C27H43N5O10S |
 |
Imatinib impurity 31 |
1356565-47-3 |
C17H17N7 |
|
|
LCZ696(valsartan + sacubitril) impurity 33 |
|
|
|
|
Lenvatinib Impurity 26 |
|
|
|
|
Ozagrel impurity C |
|
|
|
|
Regorafenib Impurity 24 |
|
|
|
|
Regorafenib Impurity 32 |
|
|
|
|
Sitafloxacin Impurity ZZ-A-01 |
|
|
 |
Solifenacin impurity 18 |
1243274-83-0 |
C14H17NO3 |
|
|
Tofacitinib Impurity 87 |
|
|
|
|
Piperacillin Impurity R |
|
|
|
|
Lasmiditan Impurity 6 |
|
|
|
|
1-methylpyrrolidin-3-yl 2-(4-chlorophenyl)-2-cyclopentyl- 2-hydroxyacetate hydrochloride |
|
|
|
|
Lasmiditan Impurity 8 |
|
|
|
|
Febuxostat Impurity 101 |
|
|
|
|
Febuxostat Impurity 105 |
|
|
|
|
(S)-10-amino-9-fluoro-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid |
|
|
 |
Ticagrelor Impurity 129 |
1381841-36-6 |
C15H19NO3 |
 |
Benzoic acid, 2-hydroxy-3-(2-phenyldiazenyl)- |
136819-59-5 |
C13H10N2O3 |
![5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio]methyl]-, 5-oxide, (6R,7R)- (9CI)](/CAS/20200611/GIF/97466-28-9.gif) |
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio]methyl]-, 5-oxide, (6R,7R)- (9CI) |
97466-28-9 |
C18H18N8O8S3 |
![1,3-Benzenediamine, 4-methyl-N3-[4-methyl-6-(3-pyridinyl)-2-pyrimidinyl]-](/CAS/20200611/GIF/1032314-73-0.gif) |
1,3-Benzenediamine, 4-methyl-N3-[4-methyl-6-(3-pyridinyl)-2-pyrimidinyl]- |
1032314-73-0 |
C17H17N5 |
|
|
5-methoxy-1-methyl-1H-benzo[d]imidazole-2-sulfonic acid |
|
|
|
|
Teneligliptin Impurity 17 |
|
|
 |
1(3H)-Isobenzofuranone, 3-(1-methylpropyl)- |
261783-87-3 |
C12H14O2 |
![Carbamic acid, N-[(1R)-2-[5-(2-fluoro-3-hydroxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-3,6-dihydro-4-methyl-2,6-dioxo-1(2H)-pyrimidinyl]-1-phenylethyl]-, 1,1-dimethylethyl ester](/CAS/20210111/GIF/1062642-68-5.gif) |
Carbamic acid, N-[(1R)-2-[5-(2-fluoro-3-hydroxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-3,6-dihydro-4-methyl-2,6-dioxo-1(2H)-pyrimidinyl]-1-phenylethyl]-, 1,1-dimethylethyl ester |
1062642-68-5 |
C32H30F5N3O5 |
 |
2-Oxazolidinone, 5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-, (5S)- |
2514942-86-8 |
C13H15NO4 |
![6-Heptenoic acid, 7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-5-hydroxy-3-oxo-, (5S,6E)-](/CAS/20200611/GIF/1803023-43-9.gif) |
6-Heptenoic acid, 7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-5-hydroxy-3-oxo-, (5S,6E)- |
1803023-43-9 |
C22H26FN3O6S |
|
|
Drug impurity detection and analysis |
|
|
![1-Pyrrolidinecarboxamide, N-[5-[(2S)-2-(2,5-difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-, (3R)-](/CAS/20210111/GIF/2409590-08-3.gif) |
1-Pyrrolidinecarboxamide, N-[5-[(2S)-2-(2,5-difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-, (3R)- |
2409590-08-3 |
C21H22F2N6O2 |
 |
Sertraline Impurity 20 |
1498236-91-1 |
C16H14Cl2O |
|
|
Budesonide Impurity 21 |
|
|
 |
2H-3-Benzazepin-2-one, 3-(3-bromopropyl)-1,3,4,5-tetrahydro-7,8-dimethoxy- |
1192174-72-3 |
C15H20BrNO3 |
 |
1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-3-(1-ethylpropoxy)-5-nitro-, ethyl ester, (3R,4R,5S)- |
949164-64-1 |
C16H26N2O6 |
|
|
Peramivir Impurity 55 |
|
|
|
|
Peramivir Impurity 60 |
|
|
 |
Hexanoic acid, 3-(hydroxymethyl)-, methyl ester, (3R)- |
2408196-94-9 |
C8H16O3 |
|
|
Loratadine EP Impurity L |
|
|
 |
Prasugrel Acetyl IMpurity |
1443034-67-0 |
C18H18FNO3S |
|
|
Propofol IMpurity G |
|
|
 |
SalMeterol IMpurity A |
|
C25H37NO4 |
|
|
Tofacitinib Impurity 92 |
|
|
 |
Amlodipine EP Impurity K |
|
C26H31ClN2O8S |
|
|
Febuxostat Impurity 49 |
|
|
 |
Budesonide Impurity 6 |
131918-73-5 |
C21H26O6 |
 |
Timolol Impurity 1 |
75014-25-4 |
C13H24N4O5S |
 |
Telmisartan EP-J |
885045-90-9 |
C33H29ClN4O2 |
 |
Pitavastatin Impurity 29 |
148516-15-8 |
C25H20FNO2 |
 |
Rosuvastatin Related Compound 6 |
521973-99-9 |
C13H23ClO4 |
 |
Medetomidine impurity |
2250243-44-6 |
C20H22N2O |
|
|
Linagliptin Impurity 51 |
|
|
|
|
Carfilzomib Impurity YGF |
|
|
 |
Pitavastatin Impurity 45 |
1258947-29-3 |
C29H32FNO4 |
|
|
Irinotecan Impurity L |
|
|
|
|
Irinotecan Impurity H |
|
|
|
|
LCZ696（valsartan + sacubitril） impurity 27 |
|
|
|
|
Caspofungin Impurity EJT2 |
|
|